The effects of basal insulin peglispro vs. insulin glargine on lipoprotein particles by NMR and liver fat content by MRI in patients with diabetes
In Phase 2/3 studies of basal insulin peglispro (BIL) compared to insulin glargine, patients with type 1 or type 2 diabetes previously treated with insulin and randomized to BIL had an increase in serum trigly...
Source: Cardiovascular Diabetology - Category: Cardiology Authors: Trevor J. Orchard, Bertrand Cariou, Margery A. Connelly, James D. Otvos, Shuyu Zhang, Caryl J. Antalis, Tibor Ivanyi and Byron J. Hoogwerf Source Type: research
More News: Cardiology | Cardiovascular | Diabetes | Diabetes Type 1 | Diabetes Type 2 | Endocrinology | Heart | Insulin | Lantus | Liver | Study | Urology & Nephrology